BioWorld - Wednesday, March 25, 2026

BioWorld Science

June 19, 1997

View Archived Issues

Centocor sells infectious disease business

Read More

Targeted Genetics receives notice of patent allowance for gene delivery technology

Read More

Targets for antimigraine therapy: antiepileptic drugs in the treatment of migraine

Read More

RPR seeks FDA approval for DDAVP tablets for bed-wetting

Read More

Almotriptan: a novel antimigraine agent from Almirall

Read More

Preclinical profile of novel migraine abortive from BMS

Read More

Joint venture formed to market RenaGel

Read More

Preclinical studies reported for rizatriptan

Read More

Allelix to form Allelix Neuroscience following acquisition of Trophix

Read More

Preclinical and clinical studies indicate safety and efficacy of SB-209509/VML-251 for migraine

Read More

Promising results reported for Senetek's INVICORP for male erectile dysfunction

Read More

Eletriptan: a safe, effective and rapid antimigraine therapy

Read More

Sugen receives notices of allowance covering SU-101 for solid tumor treatment

Read More

In vitro antifungal activity of new echinocandin derivative

Read More

FDA clears American Biogenetic Sciences' fibrinogen test

Read More

Carbamate antifungal agents

Read More

New topical imidazole antifungal from Nihon Noyaku

Read More

Antifungal plant products

Read More

Trovafloxacin modulates the in vivo activity of antifungal agents

Read More